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Received January 4, 2011; accepted June 6, 2011AbstractBackground: The aim of this study is to identify the differences between patients with overactive bladder (OAB) and detrusor overactivity (DO)
and those with OAB but without DO.
Methods: We prospectively recruited patients with OAB symptoms between December 2008 and September 2009. All patients were required to
complete a 3-day frequencyevolume chart. Symptom severity was evaluated using the International Prostate Symptom Score (IPSS) and
Overactive Bladder Symptom Score (OABSS) questionnaires. All patients also underwent urodynamic studies. Demographics, symptom
severity, urinary frequency and volume, and urodynamic variables of patients with and without DO were compared.
Results: Of the 133 enrolled patients (76 women and 57 men), DO was diagnosed in 80 patients (60.2%). All demographic variables were similar
among the OAB patients, regardless of DO status. Total IPSS and OABSS scores did not differ between the OAB and DO groups. However, the
nighttime urinary frequency subscore on the OABSS differed significantly between OAB patients with DO and without DO ( p ¼ 0.048). There
were no significant differences in terms of urodynamic variables, urinary frequency, or urine volume between OAB patients with and without DO.
Conclusion: Patients with OAB symptoms and urodynamic DO show different clinical symptoms than OAB patients without DO. Patients with
DO experience more frequent nocturnal urinary episodes.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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According to the International Continence Society (ICS)
(2002), overactive bladder (OAB) syndrome is defined as
urinary urgency, with or without urge incontinence (UUI), that
usually presents with increased frequency and nocturia
without the presence of a proven infection or other obvious
pathological condition. OAB symptoms are suggestive of
urodynamically demonstrable detrusor overactivity (DO). DO* Corresponding author. Dr. Alex T.L. Lin, Division of Urology, Department
of Surgery, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road,
Taipei 112, Taiwan, ROC.
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doi:10.1016/j.jcma.2011.08.016is a urodynamic observation characterized by involuntary
detrusor contractions during the filling phase that may be
spontaneous or provoked.1
Previously published studies show that the symptomatic
diagnosis of OAB does not correlate with urodynamically
demonstrable DO. The diagnosis of OAB, when based on
urinary symptoms, results in the underreporting of DO, and
only about 55% of patients with OAB symptoms are diag-
nosed with DO.2 Additionally, some investigators have re-
ported clinical differences between patients diagnosed with
OAB and urodynamic DO and those diagnosed with OAB but
not urodynamic DO. Patients diagnosed with OAB and DO
tend to be older and are more often incontinent.3 Nevertheless,
the actual association between OAB and DO is not clear. Thehinese Medical Association. All rights reserved.
Table 1
Demographic variables
With DO Without DO P value
Age (mean  SD yrs) 67.58  14.92 64.91  12.98 0.102
BMI S 24 (%) 53.2 57.8 0.696
Waist circumference:
M > 90 cm F > 80 cm (%)
56.4 68.2 0.299
Diabetes mellitus (%) 26.0 19.6 0.519
Hypertension (%) 48.6 43.1 0.586
Chronic pulmonary
obstructive disease (%)
6.2 4.3 1.000
Hyperlipidemia (%) 21.3 21.3 1.000
Hyperuricemia (%) 13.4 14.3 1.000
Smoking (%) 13.6 9.5 0.757
Constipation (%) 33.9 31.0 0.831
Nocturnal enuresis history (%) 22.2 18.5 0.764
DO ¼ detrusor overactivity; BMI ¼ body mass index.
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diagnosed with OAB and urodynamic DO and those with OAB
but not urodynamic DO.
2. Methods
We prospectively recruited patients with OAB symptoms
from our urology outpatient clinic between December 2008 and
September 2009. The study protocol was reviewed in advance
by the ethics committee of our hospital before any patients were
recruited. Informed consent was obtained from each patient
prior to participation in this study. All patients were interviewed
in order to obtain detailed personal and medical histories.
Patients with overt neurological disorders (e.g., spinal cord
pathology) were excluded. Among women diagnosed with
mixed urinary incontinence (MUI), only those who complained
of urgency as the dominant symptom or were equally bothered
by UUI and stress urinary incontinence (SUI) were enrolled. All
patients were required to complete a 3-day frequencyevolume
chart in order to document urinary volume, incontinence and
urgency episodes, and daytime and nighttime frequencies.
Symptom severity was evaluated using the International
Prostate Symptom Score (IPSS) and Overactive Bladder
Symptom Score (OABSS) questionnaires. The IPSS ques-
tionnaire consists of seven questions, each rated on a severity
scale of 0 to 5. The OABSS is a 4-item questionnaire devel-
oped to evaluate OAB symptoms.4 The maximal scores are 2,
3, 5, and 5 for daytime frequency, nighttime frequency,
urgency, and urgency incontinence, respectively.
All patients underwent catheter-free uroflowmetry, post-
void residual (PVR) urine measurement, and urodynamic
pressure-flow studies. Additionally, the bladder contractility
index (BCI), which was defined as the pressure at maximum
flow (PdetQmax) þ 5  the maximum flow rate (Qmax), was
calculated in men using the variables defined in a previous
urodynamic study (UDS).5 Detrusor contractility was
measured in women using the modified projected iso-
volumetric pressure (PIP1) index, which was calculated by
adding Qmax to PdetQmax to the usual urodynamic units.6
Male bladder outlet obstruction (BOO) was defined based on
a provisional ICS method for the definition of obstruction,
which defined BOO as (PdetQmax  2Qmax) > 40.7 PSA
levels and prostate size were also measured in men.
The demographics, IPSS scores, OABSS scores, fre-
quencyevolume charts, and urodynamic variables were
compared between patients with and without DO. The Mann-
Whitney U-test was used to analyze the continuous variables,
and the Fisher’s exact test was used to analyze the categorical
variables. p-values < 0.05 were considered statistically
significant. Except for the urodynamic variables that were
separately analyzed for men and women, all other variables
were analyzed regardless of gender.
3. Results
The mean age of the patients was 66.5  11.1 years (range:
23e88 years). DO was diagnosed in 80 patients (60.2%),including 42 women (55.3%) and 38 men (66.7%). The
percentages of men and women with DO and OAB did not
differ significantly. Among the men diagnosed with DO, 9
(23.7%) were also diagnosed with BOO. Among the women
diagnosed with DO, 12 (28.6%) were also diagnosed with
MUI. Most of the women with MUI complained of urgency as
the dominant symptom, except for three patients who were
equally bothered by UUI and SUI. Demographic variables,
including age, body mass index (BMI), waist circumference,
concomitant systemic diseases, smoking habits, constipation,
and histories of primary nocturnal enuresis, were similar
between OAB patients regardless of DO status (Table 1). In
women with OAB, SUI and menopause did not increase the
probability of presenting with DO. In men with OAB, neither
prostate-specific antigen (PSA) levels nor prostate size were
associated with a diagnosis of DO. Additionally, among men
with DO, a diagnosis of BOO was not associated with larger
prostates.
The IPSS and OABSS scores did not differ between the two
groups; however, the subscore for nighttime frequency on the
OABSS differed significantly between OAB patients regard-
less of DO status ( p ¼ 0.048). The median subscore for
nighttime frequency of patients with DO was 3 (range: 0e3),
while the median subscore of patients without DO was 2
(range: 0e3). The probability of presenting with DO increased
as the severity of nocturia increased.
Except for the bladder volume at the first desire to void, and
bladder capacity, which were both lower in both men and
women with OAB and DO, there were no significant differ-
ences between men with OAB and women, regardless of DO
status, in terms of the results of the PVR variable examina-
tions, catheter-free uroflowmetry, or urodynamic pressure-flow
studies (including the maximum flow rate, maximal detrusor
pressure, detrusor pressure at maximal flow, and BCI for men
and PIP1 for women) (Tables 2 and 3). Among men with DO,
a diagnosis of BOO was not associated with a low flow rate.
There were no significant differences in the variables
measured on the frequencyevolume charts (24-hour frequency,
number of urgent urinary incontinence episodes, nocturia,
nocturnal urine ratio, 24-hour urine production, and maximal
Table 2
Urodynamic study results for men
With DO Without DO P value
First desire to void
(mean  SD ml)
68.54  37.61 168.11  98.35 <0.001
Cystometric capacity
(mean  SD ml)
96.74  48.53 286.21  107.06 <0.001
Free Qmax (mean  SD ml/sec) 16.37  8.97 22.07  10.50 0.120
Free Qmean
(mean  SD ml/sec)
9.11  4.85 11.59  5.79 0.213
Post-void residual
(mean  SD ml)
71.96  98.45 48.89  50.86 0.649
BCI (mean  SD) 101.4  36.25 93.84  32.97 0.400
MaxPdet (mean  SD cmH2O) 64.17  33.27 52.11  37.12 0.062
PdetQmax
(mean  SD cmH2O)
64.5  27.15 56.75  26.45 0.464
DO ¼ detrusor overactivity; Free Qmax ¼ catheter-free maximum flow rate;
Free Qmean ¼ catheter-free average flow rate; BCI ¼ bladder contractility
index; MaxPdet¼maximum pressure; PdetQmax¼ pressure at maximum flow.
Table 4
Frequency volume chart variables
With DO Without DO P value
24 hour frequency
(mean  SD)
11.26  3.64 11.01  4.30 0.613
24 hour production
(mean  SD ml)
1764.54  691.95 1784.49  643.93 0.820
Maximum voided volume
(mean  SD ml)
337.50  98.12 383.93  155.93 0.207
Minimum voided volume
(mean  SD ml)
53.88  35.91 55.73  31.99 0.428
Nocturia (mean  SD) 2.04  1.26 1.91  1.59 0.447
Urge urinary incontinence
(mean  SD)
1.63  2.37 1.16  1.67 0.336
Urgency (mean  SD) 2.62  3.06 1.9  2.37 0.165
Nocturnal urine ratio (%) 34.28 33.22 0.960
First morning void
(mean  SD ml)
200.72  89.29 214.24  119.18 0.692
DO ¼ detrusor overactivity.
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without DO (Table 4).
4. Discussion
Previous studies have reported that conventional UDS is
neither sensitive nor specific in regard to urodynamic DO or
the subjective symptoms of OAB. The diagnosis of OAB is
based on urinary symptoms, and only about 55% of patients
with OAB symptoms are diagnosed with DO.2 Similarly, in
this study, about 60% of patients with OAB were also diag-
nosed with DO. On the contrary, a previous study reported that
about 40% of men and 30% of women without OAB symp-
toms also present with DO, according to the definitions of
UDS.8
Previously reported studies also report that OAB patients
with nocturia and/or UUI are at high risk of being diagnosed
with DO on urodynamic evaluation. Hashim and AbramsTable 3
Urodynamic study results for women
With DO Without DO P value
First desire to void
(mean  SD ml)
71.06  43.75 155.89  78.80 <0.001
Cystometric capacity
(mean  SD ml)
131.68  76.26 284.14  104.24 <0.001
Free Qmax (mean  SD ml/sec) 35.68  18.83 32.45  15.37 0.658
Free Qmean
(mean  SD ml/sec)
18.81  9.47 16.43  10.61 0.272
Post-void residual
(mean  SD ml)
11.84  14.96 38  50.38 0.077
PIP1 (mean  SD) 45.41  21.77 43.29  16.51 0.748
MaxPdet (mean  SD cmH2O) 43.47  40.70 31.25  15.93 0.508
PdetQmax
(mean  SD cmH2O)
31.79  25.09 33.67  17.58 0.317
DO ¼ detrusor overactivity; Free Qmax ¼ catheter-free maximum flow rate;
Free Qmean ¼ catheter-free average flow rate; PIP1 ¼ projected isovolumetric
pressure; MaxPdet ¼ maximum pressure; PdetQmax ¼ pressure at maximum
flow.stated that urgency, UUI, and nocturia significantly increase
the chances of developing DO.8 In addition, UUI and nocturia
were associated with DO in the study performed by Khan
et al.9 However, in this study, only nocturia was found to be
a significant predictor of DO, and the probability of presenting
with DO increased as the severity of nocturia increased. The
reason why this study does not indicate UUI as a predictor of
developing DO might be due to the high incidence of UUI in
our patients. Approximately 86.3% of our patients were
diagnosed with UUI, which is significantly higher than the rate
of 25% reported in the study performed by Hashim and
Abrams.8 The study group described here presented with more
severe OAB symptoms than most patients with UUI, rendering
UUI as an unreliable predictor. Krystal et al reported that
nocturnal DO often occurs in association with nocturia in most
patients diagnosed with DO and OAB.10 Detrusor instability
also plays a role in the pathophysiology of nocturia, similar to
how it plays a role in the occurrence of daytime voiding in
those diagnosed with DO and OAB. Therefore, nocturia is
considered a valuable predictor of DO.
It is interesting to note that the objective recording of
nocturnal frequency on the frequencyevolume charts did not
differ statistically between patients with and without DO. Stav
et al suggested that there is a weak correlation between urinary
frequencies obtained from medical histories and the frequen-
cies recorded in diaries.11 In this study, patients used a 3-day
frequencyevolume chart to accurately record the frequency of
nocturia. OABSS was used to evaluate lower urinary tract
symptoms among OAB patients over a 1-week period, which
grades nocturia on a 4-point scale. The accuracy of the fre-
quencyevolume chart depends on the patient’s cooperation,
age, and level of cognitive abilities. All of these factors could
result in discrepancies between the patient’s subjective reports
regarding nocturnal frequency and the objective recording of
nocturnal frequency using the frequencyevolume chart.
Haylen et al reported that DO patients tend to be older.3
Similarly, Guralnick et al stated that patients with DO are
older.12 However, age was not a significant predictor of DO in
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demographic variables and DO; however, we extensively
evaluated several demographic variables, including age,
concomitant systemic diseases, smoking habits, constipation,
menopause, coexistence of SUI, and history of primary
nocturnal enuresis, to determine which factors might serve as
predictors of urodynamic DO in OAB patients. Regardless, no
significant demographic predictors were revealed in this study.
Blaivas et al proposed that most men with OAB also have
coexisting urological problems.13 Their data shows that the
most common diagnoses were benign prostatic enlargement
(32% of cases), BOO (22%), and complications following
prostate cancer treatment (20%). Idiopathic OAB was diag-
nosed in only 5% of their study population. Furthermore,
between 46% and 66% of men with prostatic obstruction on
urodynamic studies are diagnosed with DO.14e16 A previous
study also showed a statistically significant correlation
between BOO and prostate size.17 We compared prostate sizes
between men with OAB and DO and those without DO,
however no significant difference in prostate size was found.
Additionally, among men with DO, the coexistence of BOO
did not relate to large prostate size or low urinary flow.
In the urodynamic portion of this study, the bladder volume
at the first desire to void and cystometric capacity were lower
in both men and women diagnosed with OAB and DO.
Sensory urgency is generally defined as increased bladder
sensation during filling, a low first desire to void, and low
bladder capacity in the absence of a known urinary tract
infection or DO. Hyalen et al stated that sensory urgency
belongs in the same spectrum of bladder dysfunction as DO.3
Guralnick et al reported that infused volumes are significantly
smaller in patients with UDS-proven DO when there is
a strong urge to urinate although no differences were noted in
the bladder sensation at first desire to void.12 Other UDS
variables did not differ significantly between men and women
with OAB, regardless of DO status. Similarly, the variables
recorded on the frequencyevolume charts did not help make
differential diagnoses. Guralnick et al found that patients with
DO had smaller maximum volumes per void, decreased 24-hour
urine outputs, and a higher number of incontinent episodes.12 A
previous study also revealed that a voiding diary, assuming that
the directions are properly followed, is reliable and appears to
be suitable for documenting changes in the symptoms of OAB
patients.18 However, among noncompliant patients, the absence
of urinary symptoms is frequently encountered.19 Detailed and
accurate recording on frequencyevolume charts is critical for
diagnosis.
Although the present study found that nocturnal frequency,
when subjectively recorded, is more frequent in OAB patients
with DO, this finding is only an academic interest. We are still
unable to explain this finding based on the current under-
standing of the molecular mechanisms involved in bladder
sensation, particularly those that occur during sleep. There-
fore, the empirical use of pharmacological agents, without
UDS, to treat OAB symptoms continues to be the treatment
standard. UDS is used only if medical treatment fails or
unexplainable emptying symptoms also present.A limitation of this study is that the sample size was small,
so selection bias could have occurred. Also, prostate size was
defined as a two-category variable, and the cutoff value was
40 g; however, there is no consensus regarding what represents
a small or large prostate, and our size limits do not reflect any
standardized measurements. The study group should be
expanded in future studies in order to confirm the findings
observed here.
In conclusion, OAB patients with DO experience more
nocturia episodes, as determined by the results of the OABSS
questionnaire. This finding should be verified using a larger
study population.
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